Literature DB >> 13673091

Combined drug treatment of tuberculosis. I. Prevention of emergence of mutant populations of tubercle bacilli resistant to both streptomycin and isoniazid in vitro.

M L COHN, G MIDDLEBROOK, W F RUSSELL.   

Abstract

Entities:  

Keywords:  ISONIAZID/effects; MYCOBACTERIUM TUBERCULOSIS/effect of drugs on; STREPTOMYCIN/effects

Mesh:

Substances:

Year:  1959        PMID: 13673091      PMCID: PMC442089          DOI: 10.1172/JCI103910

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  9 in total

1.  Studies on the stability of isoniazid.

Authors:  E LEWIN; J G HIRSCH
Journal:  Am Rev Tuberc       Date:  1955-05

2.  Studies on isoniazid and tubercle bacilli. III. The isolation, drug-susceptibility, and catalase-testing of tubercle bacilli from isoniazid-treated patients.

Authors:  G MIDDLEBROOK; M L COHN; W B SCHAEFER
Journal:  Am Rev Tuberc       Date:  1954-11

3.  United States Public Health service cooperative investigation of antimicrobial therapy of tuberculosis, V. Report on thirty-two-week observations on combinations of isoniazid, streptomycin, and para-aminosalicylic acid.

Authors:  F W MOUNT; S H FEREBEE
Journal:  Am Rev Tuberc       Date:  1954-09

4.  Studies on isoniazid and tubercle bacilli. I. The isolation of isoniazid-resistant mutants in vitro.

Authors:  M L COHN; U ODA; C KOVITZ; G MIDDLEBROOK
Journal:  Am Rev Tuberc       Date:  1954-09

5.  Bactericidal activity of streptomycin and isoniazid against tubercle bacilli.

Authors:  B SINGH; D A MITCHISON
Journal:  Br Med J       Date:  1954-01-16

6.  Control study of comparative efficacy of isoniazid, streptomycin-isoniazid, and streptomycin; para-aminosalicylic acid in pulmonary tuberculosis therapy. IV. Report on forty-week observations on 583 patients with streptomycin susceptible infections.

Authors:  F W MOUNT; B E JENKINS; S H FEREBEE
Journal:  Am Rev Tuberc       Date:  1953-08

7.  Origin of Bacterial Resistance to Antibiotics.

Authors:  M Demerec
Journal:  J Bacteriol       Date:  1948-07       Impact factor: 3.490

8.  Studies on isoniazid and tubercle bacilli. II. The growth requirements, catalase activities, and pathogenic properties of isoniazid-resistant mutants.

Authors:  M L COHN; C KOVITZ; U ODA; G MIDDLEBROOK
Journal:  Am Rev Tuberc       Date:  1954-10

9.  Sterilization of tubercle bacilli by isonicotinic acid hydrazide and the incidence of variants resistant to the drug in vitro.

Authors:  G MIDDLEBROOK
Journal:  Am Rev Tuberc       Date:  1952-06
  9 in total
  11 in total

1.  Combined drug treatment of tuberculosis. II. Studies of antimicrobially-active isoniazid and streptomycin serum levels in adult tuberculous patients.

Authors:  W MANDEL; A D HEATON; W F RUSSELL; G MIDDLEBROOK
Journal:  J Clin Invest       Date:  1959-08       Impact factor: 14.808

2.  Combined drug treatment of tuberculosis. III. Clinical application of the principles of appropriate and adequate chemotherapy to the treatment of pulmonary tuberculosis.

Authors:  W F RUSSELL; I KASS; A D HEATON; S H DRESSLER; G MIDDLEBROOK
Journal:  J Clin Invest       Date:  1959-08       Impact factor: 14.808

Review 3.  Minority variants of drug-resistant HIV.

Authors:  Sara Gianella; Douglas D Richman
Journal:  J Infect Dis       Date:  2010-09-01       Impact factor: 5.226

4.  The virulence in the guinea-pig of tubercle bacilli isolated before treatment from South Indian patients with pulmonary tuberculosis. I. Homogeneity of the investigation and a critique of the virulence test.

Authors:  D A MITCHISON; A L BHATIA; S RADHAKRISHNA; J B SELKON; T V SUBBAIAH; J G WALLACE
Journal:  Bull World Health Organ       Date:  1961       Impact factor: 9.408

5.  Some Thoughts on the Antibiotic Therapy of Orthopaedic Tuberculosis [Summary].

Authors:  H R Lunt
Journal:  Proc R Soc Med       Date:  1960-06

6.  The virulence in the guinea-pig of tubercle bacilli isolated before treatment from South Indian patients with pulmonary tuberculosis. 2. Comparison with virulence of tubercle bacilli from British patients.

Authors:  A L BHATIA; A CSILLAG; D A MITCHISON; J B SELKON; P R SOMASUNDARAM; T V SUBBAIAH
Journal:  Bull World Health Organ       Date:  1961       Impact factor: 9.408

7.  Profound depletion of HIV-1 transcription in patients initiating antiretroviral therapy during acute infection.

Authors:  Adrian Schmid; Sara Gianella; Viktor von Wyl; Karin J Metzner; Alexandra U Scherrer; Barbara Niederöst; Claudia F Althaus; Philip Rieder; Christina Grube; Beda Joos; Rainer Weber; Marek Fischer; Huldrych F Günthard
Journal:  PLoS One       Date:  2010-10-12       Impact factor: 3.240

8.  A VERTICAL DIFFUSION METHOD FOR THE MICROBIOLOGICAL ASSAY OF ISONIAZID.

Authors:  J LLOYD; D A MITCHISON
Journal:  J Clin Pathol       Date:  1964-11       Impact factor: 3.411

9.  Rate of inactivation of isoniazid in South Indian patients with pulmonary tuberculosis.

Authors:  P R GANGADHARAM; A L BHATIA; S RADHAKRISHNA; J B SELKON
Journal:  Bull World Health Organ       Date:  1961       Impact factor: 9.408

10.  Identification of tubercle bacilli from Indian patients with pulmonary tuberculosis.

Authors:  K L THOMAS; S JOSEPH; T SUBBAIAH; J B SELKON
Journal:  Bull World Health Organ       Date:  1961       Impact factor: 9.408

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.